HU170250B - - Google Patents
Info
- Publication number
- HU170250B HU170250B HUBE1262A HUBE001262A HU170250B HU 170250 B HU170250 B HU 170250B HU BE1262 A HUBE1262 A HU BE1262A HU BE001262 A HUBE001262 A HU BE001262A HU 170250 B HU170250 B HU 170250B
- Authority
- HU
- Hungary
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9515/75A GB1532993A (en) | 1975-03-07 | 1975-03-07 | Injectable antibiotic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU170250B true HU170250B (en:Method) | 1977-05-28 |
Family
ID=9873459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUBE1262A HU170250B (en:Method) | 1975-03-07 | 1976-02-25 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4876086A (en:Method) |
| JP (1) | JPS5914004B2 (en:Method) |
| AR (1) | AR211700A1 (en:Method) |
| AT (1) | AT344317B (en:Method) |
| AU (1) | AU502790B2 (en:Method) |
| BE (1) | BE839109A (en:Method) |
| CA (1) | CA1045549A (en:Method) |
| DD (1) | DD124866A5 (en:Method) |
| DE (1) | DE2608079C2 (en:Method) |
| DK (1) | DK153123C (en:Method) |
| FI (1) | FI760503A7 (en:Method) |
| FR (1) | FR2302736A1 (en:Method) |
| GB (1) | GB1532993A (en:Method) |
| GR (1) | GR59302B (en:Method) |
| HU (1) | HU170250B (en:Method) |
| IE (1) | IE42951B1 (en:Method) |
| IL (1) | IL49009A (en:Method) |
| IT (1) | IT1061681B (en:Method) |
| MX (1) | MX5599E (en:Method) |
| NL (1) | NL187835C (en:Method) |
| NO (1) | NO760767L (en:Method) |
| NZ (1) | NZ179948A (en:Method) |
| PT (1) | PT64813B (en:Method) |
| SE (1) | SE425762B (en:Method) |
| ZA (1) | ZA76926B (en:Method) |
| ZM (1) | ZM2076A1 (en:Method) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7714312L (sv) * | 1976-12-17 | 1978-06-18 | Scherico Ltd | Antibiotiska kompositioner |
| DE2964817D1 (en) * | 1978-09-06 | 1983-03-24 | Beecham Group Plc | Pharmaceutical compositions containing two beta-lactam derivatives |
| EP0012495B1 (en) * | 1978-12-08 | 1983-06-22 | Beecham Group Plc | Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition |
| DE3266580D1 (en) * | 1981-12-02 | 1985-10-31 | Beecham Group Plc | Pharmaceutical formulation comprising beta-lactam antibiotics |
| FR2594334B1 (fr) * | 1986-02-20 | 1990-01-12 | Bristol Myers Co | Composition pharmaceutique injectable a base d'amoxicilline |
| GB8629481D0 (en) * | 1986-12-10 | 1987-01-21 | Beecham Group Plc | Veterinary treatment |
| US4898728A (en) * | 1988-04-07 | 1990-02-06 | Beecham Group P.L.C. | Process for production of composition containing lecithin and polyvinylpyrrolidone |
| IT1230095B (it) * | 1989-04-27 | 1991-10-05 | Parenta Srl | Procedimento per la preparazione di forme sterili di polveri iniettabili di antibiotici. |
| MX9201782A (es) * | 1991-04-19 | 1992-10-01 | Sandoz Ag | Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene. |
| US6447806B1 (en) | 1999-02-25 | 2002-09-10 | Novartis Ag | Pharmaceutical compositions comprised of stabilized peptide particles |
| WO2000050036A1 (en) * | 1999-02-26 | 2000-08-31 | Biovail International Ltd. | Storage stable amoxycillin and clavulanate suspension composition |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB660511A (en) * | 1948-07-14 | 1951-11-07 | Squibb & Sons Inc | Penicillin compositions and methods of preparing them |
| GB705343A (en) * | 1952-02-01 | 1954-03-10 | Lilly Co Eli | Improvements in or relating to aqueous suspensions of procaine penicillin |
| US2897120A (en) * | 1954-05-04 | 1959-07-28 | Upjohn Co | Low viscosity cmc pharmaceutical vehicle |
| US2939818A (en) * | 1957-04-09 | 1960-06-07 | Pfizer & Co C | Aqueous therapeutic compositions |
| US3062718A (en) * | 1959-10-27 | 1962-11-06 | Pfizer & Co C | Stable aqueous streptomycinpenicillin composition |
| BE719923A (en:Method) * | 1964-05-20 | 1969-02-24 | ||
| DE1901915C3 (de) * | 1968-01-18 | 1980-08-21 | Bristol-Myers Co., New York, N.Y. (V.St.A.) | Arzneimittel auf der Basis von a -Aminobenzylpenicillintrihydrat |
| GB1241844A (en) * | 1968-08-23 | 1971-08-04 | Beecham Group Ltd | Penicillins |
| US3634586A (en) * | 1968-12-04 | 1972-01-11 | Bristol Myers Co | Stable aqueous suspensions of ampicillin |
| US3703511A (en) * | 1969-06-06 | 1972-11-21 | Squibb & Sons Inc | Alpha-aminobenzyl penicillins |
| US3737545A (en) * | 1972-02-22 | 1973-06-05 | Squibb & Sons Inc | Alpha-aminobenzyl penicillins |
| GB1403584A (en) * | 1972-05-19 | 1975-08-28 | Beecham Group Ltd | Control medicaments |
| US3969524A (en) * | 1974-08-13 | 1976-07-13 | Hoffmann-La Roche Inc. | Stable amoxicillin dosage form |
| EP0012495B1 (en) * | 1978-12-08 | 1983-06-22 | Beecham Group Plc | Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition |
-
1975
- 1975-03-07 GB GB9515/75A patent/GB1532993A/en not_active Expired
-
1976
- 1976-02-09 NZ NZ179948A patent/NZ179948A/xx unknown
- 1976-02-10 GR GR50009A patent/GR59302B/el unknown
- 1976-02-10 IE IE261/76A patent/IE42951B1/en unknown
- 1976-02-10 IL IL49009A patent/IL49009A/xx unknown
- 1976-02-11 SE SE7601535A patent/SE425762B/xx not_active IP Right Cessation
- 1976-02-13 ZM ZM20/76A patent/ZM2076A1/xx unknown
- 1976-02-17 ZA ZA926A patent/ZA76926B/xx unknown
- 1976-02-18 PT PT64813A patent/PT64813B/pt unknown
- 1976-02-25 HU HUBE1262A patent/HU170250B/hu unknown
- 1976-02-26 AR AR262385A patent/AR211700A1/es active
- 1976-02-26 FI FI760503A patent/FI760503A7/fi not_active Application Discontinuation
- 1976-02-27 DE DE2608079A patent/DE2608079C2/de not_active Expired
- 1976-02-27 FR FR7605542A patent/FR2302736A1/fr active Granted
- 1976-03-01 CA CA246,820A patent/CA1045549A/en not_active Expired
- 1976-03-02 BE BE164789A patent/BE839109A/xx not_active IP Right Cessation
- 1976-03-03 AT AT156576A patent/AT344317B/de not_active IP Right Cessation
- 1976-03-03 NL NLAANVRAGE7602180,A patent/NL187835C/xx not_active IP Right Cessation
- 1976-03-05 IT IT48427/76A patent/IT1061681B/it active
- 1976-03-05 NO NO760767A patent/NO760767L/no unknown
- 1976-03-05 DK DK098076A patent/DK153123C/da not_active IP Right Cessation
- 1976-03-05 MX MX7643U patent/MX5599E/es unknown
- 1976-03-05 DD DD191720A patent/DD124866A5/xx unknown
- 1976-03-08 AU AU11789/76A patent/AU502790B2/en not_active Expired
- 1976-03-08 JP JP51024278A patent/JPS5914004B2/ja not_active Expired
-
1987
- 1987-09-17 US US07/098,326 patent/US4876086A/en not_active Expired - Lifetime